AGL 40.05 Increased By ▲ 0.04 (0.1%)
AIRLINK 190.98 Increased By ▲ 3.00 (1.6%)
BOP 10.25 Increased By ▲ 0.13 (1.28%)
CNERGY 7.22 Increased By ▲ 0.11 (1.55%)
DCL 10.27 Increased By ▲ 0.12 (1.18%)
DFML 42.04 Increased By ▲ 0.47 (1.13%)
DGKC 108.39 Increased By ▲ 0.48 (0.44%)
FCCL 38.49 Decreased By ▼ -0.51 (-1.31%)
FFBL 90.22 Increased By ▲ 8.20 (10%)
FFL 14.93 Increased By ▲ 0.03 (0.2%)
HUBC 123.00 Increased By ▲ 3.54 (2.96%)
HUMNL 14.31 Increased By ▲ 0.26 (1.85%)
KEL 6.30 Decreased By ▼ -0.10 (-1.56%)
KOSM 8.36 Increased By ▲ 0.29 (3.59%)
MLCF 48.99 Decreased By ▼ -0.48 (-0.97%)
NBP 74.25 Increased By ▲ 0.59 (0.8%)
OGDC 212.00 Increased By ▲ 7.15 (3.49%)
PAEL 32.90 Decreased By ▼ -0.66 (-1.97%)
PIBTL 9.07 Increased By ▲ 1.00 (12.39%)
PPL 201.04 Increased By ▲ 15.63 (8.43%)
PRL 34.52 Increased By ▲ 0.91 (2.71%)
PTC 27.40 Increased By ▲ 0.01 (0.04%)
SEARL 117.70 Decreased By ▼ -2.12 (-1.77%)
TELE 9.80 Increased By ▲ 0.11 (1.14%)
TOMCL 35.30 No Change ▼ 0.00 (0%)
TPLP 12.50 Increased By ▲ 0.25 (2.04%)
TREET 22.29 Increased By ▲ 2.03 (10.02%)
TRG 61.00 Increased By ▲ 0.22 (0.36%)
UNITY 36.70 Decreased By ▼ -1.29 (-3.4%)
WTL 1.79 Increased By ▲ 0.14 (8.48%)
BR100 12,159 Increased By 386.9 (3.29%)
BR30 37,770 Increased By 1185.5 (3.24%)
KSE100 114,181 Increased By 3370.3 (3.04%)
KSE30 35,701 Increased By 1272.1 (3.69%)

KARACHI: Haleon Pakistan plans to start manufacturing multivitamin brand Centrum in the country for domestic sales and export, its CEO said, as it seeks to boost sales in the country amid lower inflation.

The Pakistan unit of British consumer healthcare firm Haleon plans to expand its pain management offerings next year by adding the Panadol range for menstrual pain and migraines, CEO Farhan Muhammad Haroon told Reuters in an interview.

“Pakistan has a Rs24-billion ($86.30 million) Vitamin Mineral Supplement market. This does not include the grey market. We already make up Rs7.5 billion ($26.97 million) of the market through our (vitamin) products CAC-1000 Plus and Qalsium-D,” said Haroon.

“With the launch of Centrum, we plan to capture 7 to 8% of the remaining market immediately, which is a sizeable portion of the category.”

Pakistan’s Citi Pharma, Martin Dow partner with Chinese firm for biotech manufacturing

Haroon said the company plans to sell Centrum in smaller bottles so customers do not have to worry about high upfront costs, as purchasing power has diminished in the country after inflation hit a multidecade high of around 40% last year. In November, Pakistan’s consumer price index inflation slowed to 4.9%.

Haroon said in the first stage of the Centrum launch, expected in the first quarter of 2025, the product will be imported, and in the second stage it will be made locally with market specific variants to suit needs of Pakistanis and other export markets.

“We already export our calcium and vitamin D supplement CAC-1000 Plus and topical pain relief product Voltral Emulgel to Vietnam and Philippines, we will be ready to export to 19 countries in the next 1-1.5 years,” he said.

Haleon Pakistan sees at least 10% of its sales coming from exports in the next two years, up from 5%-6% during its peak in 2022, Haroon said, adding that it had invested $10 million last year to enhance local production capabilities.

Comments

200 characters